Search results
Results from the WOW.Com Content Network
Example of some 200 mg ibuprofen tablets A 150 ml bottle (100 mg/5 ml dosage) of ibuprofen, sold in Greece. Ibuprofen is used primarily to treat fever (including postvaccination fever), mild to moderate pain (including pain relief after surgery), painful menstruation, osteoarthritis, dental pain, headaches, and pain from kidney stones.
Nurofen is a brand of range of pain-relief medication containing ibuprofen made by the English-Dutch company Reckitt Benckiser. [1] Introduced in 1983, the Nurofen brand was acquired following Reckitt Benckiser's acquisition of Boots healthcare international in 2005 for £1.93 billion, which included Nurofen, Strepsils, and Clearasil. [2]
Name Available forms Available strengths Countries Act-3: Actiprofen: Canada [3]: Actron: Argentina, Uruguay, Chile Adagin: Romania Addaprin: USA [3]: Adex: Israel ...
The details of label includes the name of preparation, quantity of drugs, instructions for patients, patient's name and the date of dispensing Drug labelling , also referred to as prescription labelling , is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug.
Codeine is marketed as both a single-ingredient drug and in combination preparations with paracetamol (as co-codamol: e.g., brands Paracod, Panadeine, and the Tylenol-with-codeine series, including Tylenol 3 and 1, 2, and 4); with aspirin (as co-codaprin); or with ibuprofen (as Nurofen Plus).
An auxiliary label (also called cautionary and advisory label or prescription drug warning label) is a label added on to a dispensed medication package by a pharmacist in addition to the usual prescription label. These labels are intended to provide supplementary information regarding the safe administration, use, and storage of the medication. [1]
By the late 1980s, Nurofen had a 12% share of the analgesics market. Gold Greenlees Trott (GGT), who later bought BBDP then were bought by Omnicom Group in 1998 and made part of TBWA Worldwide, were commissioned to make an advert to markedly increase Nurofen's market share. Analgesics are mainly purchased by 25- to 40-year-old women.
Making Nurofen into Nurofen (product) and creating a Nurofen (brand) just to remove Nurofen Plus seems illogical. -- Thecurran ( talk ) 02:55, 20 January 2008 (UTC) [ reply ] Blatant advert?